Cas:2379-56-8 6-Nitrochinoxalin-2,3-diol manufacturer & supplier

Chemical Name:6-Nitrochinoxalin-2,3-diol

CAS.NO:2379-56-8

Synonyms:2,3-quinoxalinedione, 1,4-dihydro-6-nitro-;6-nitroquinoxaline-2,3(1H,4H)-dione;6-Nitro-2,3-dihydroxyquinoxaline;6-Nitro Quinoxaline-2,3-Dion;MFCD00673833;6-Nitro-1,4-dihydroquinoxaline-2,3-dione6-Nitroquinoxaline-2,3-dione;6-Nitro-1,4-dihydro-chinoxalin-2,3-dion;6-nitro-1,4-dihydroquinoxaline-2,3-dione;6-nitro-1,4-dihydro-quinoxaline-2,3-dione;6-Nitro-1,4-dihydro-2,3-quinoxalinedione;6-NITROQUINOXALINE-2,3-DIOL;6-nitro-1,2,3,4-tetrahydroquinoxaline-2,3-dione;6-Nitrochinoxalin-2,3-diol;REF DUPL: 6-Nitroquinoxaline-2,3-dione;6-Nitro-2,3-dihydroxyquinoxaline,6-Nitroquinoxaline-2,3-dione

Molecular Formula:C₈H₅N₃O₄

Molecular Weight:207.143

HS Code:

Physical and Chemical Properties:

Melting point:>300°C (dec.)

Boiling point:574.4±45.0 °C at 760 mmHg

Density:1.7±0.1 g/cm3

Index of Refraction:1.797

PSA:112.06000

Exact Mass:207.028000

LogP:2.39

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2,3-quinoxalinedione, 1,4-dihydro-6-nitro- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Nitro-2,3-dihydroxyquinoxaline,6-Nitroquinoxaline-2,3-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Nitrochinoxalin-2,3-diol Use and application,6-Nitro-1,4-dihydro-2,3-quinoxalinedione technical grade,usp/ep/jp grade.

Related News: Charles River looks forward to continuing its ongoing partnership with AstraZeneca. It was great to join the team today, to see the facility for myself and congratulate them on this really significant expansion, which will see an €8m investment, creating 90 new jobs for Mayo. phosphonic acid bis-(2-fluoro-ethyl) ester manufacturers The company was one of many to step into the void for needed generic medicines as chronic shortages crippled access to key drugs, specifically in the early- to mid-stages of the pandemic. That shortage actually led the FDA to thaw its relationship with compounding pharmacies — which was once particularly icy — to ramp up production. (R)-4-(4-(4-carbamoylphenoxy)-2-((1-(naphthalen-1-yl)ethyl)carbamoyl)phenyl)butanoic acid suppliers Mindset was established in order to develop next generation pharmaceutical assets that leverage the breakthrough therapeutic potential of psychedelic drugs. Benzo[h]quinolin-2(1H)-one,3-[3,4-dihydro-4-(2-propenyl)-3-thioxo-1,2,4-triazin-5-yl]-4-hydroxy- vendor & factory.